EE416 Cost-Effectiveness of Pembrolizumab Monotherapy for First-Line Treatment in Adult Patients with Microsatellite Instability High/Mismatch Repair-Deficient Metastatic Colorectal Cancer From a French Perspective
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.662
https://www.valueinhealthjournal.com/article/S1098-3015(22)02866-2/fulltext
Title :
EE416 Cost-Effectiveness of Pembrolizumab Monotherapy for First-Line Treatment in Adult Patients with Microsatellite Instability High/Mismatch Repair-Deficient Metastatic Colorectal Cancer From a French Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02866-2&doi=10.1016/j.jval.2022.09.662
First page :
Section Title :
Open access? :
No
Section Order :
10197